
# Title 21— FOOD AND DRUGS
### CHAPTER 13— DRUG ABUSE PREVENTION AND CONTROL
#### § 825. Labeling and packaging
##### (e) False labeling of anabolic steroids
######## (B) A product is described in this subparagraph if the product

(i) is the subject of an approved application as described in section 505(b) or (j) of the Federal Food, Drug, and Cosmetic Act [ 21 U.S.C. 355(b) , (j)]; or

(ii) is exempt from the provisions of section 505 of such Act relating to new drugs because

(I) it is intended solely for investigational use as described in section 505(i) of such Act; and

(II) such product is being used exclusively for purposes of a clinical trial that is the subject of an effective investigational new drug application.
